US Patent

US9095509 — Sachet formulation for amine polymers

Formulation · Assigned to Genzyme Corp · Expires 2030-12-06 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a powder formulation of an aliphatic amine polymer or a pharmaceutically acceptable salt thereof, packaged in a container such as a sachet.

USPTO Abstract

A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US9095509
Jurisdiction
US
Classification
Formulation
Expires
2030-12-06
Drug substance claim
No
Drug product claim
Yes
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.